Rare diseases
Investigational molecules
Locations
Back to Belgium1 clinical trial in Zwijnaarde, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focusing on SARS-CoV-2 immunity patterns in diverse population groups, with special attention to immunocompromised individuals.
The study encompasses various vulnerable populations including nursing home residents, dialysis patients, and transplant recipients, contributing to our understanding of COVID-19 immunity in at-risk groups.
Specialized investigation tracking immune responses in kidney and lung transplant patients, providing crucial data for immunocompromised patient care.
This Belgian research initiative aims to enhance understanding of vaccine effectiveness and immune protection in transplant recipients.
Comprehensive longitudinal study examining COVID-19 immunity across different population segments in Belgium's healthcare system.
The research spans multiple years (2023-2026) to provide valuable insights for public health policy and patient care protocols.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
